Back to Trades
Gabay Avraham
Chief Financial OfficerCIK 0001777328
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2026
Gabay Avraham, Chief Financial Officer, has filed 6 SEC reports (2026), spread across 2 companies, totaling $90.2K in disclosed volume. Weighing $0 bought versus $90.2K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 2 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Sell | $90.2K |
| Sep 25 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Grant | $0 |
| Aug 24 | LFWD Lifeward Ltd. | Gabay Avraham | Director | Grant | $0 |
| Aug 24 | LFWD Lifeward Ltd. | Gabay Avraham | Director | Other | $0 |
| Mar 18 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Grant | $0 |
| Jan 29 | ORMP ORAMED PHARMACEUTICALS INC. | Gabay Avraham | Chief Financial Officer | Exercise | $0 |
6 filings